# Paul W. Wallace, MD – FDA Inspection, Jun 8, 2018

Source: https://www.keypedia.com/records/fda_inspections/paul-w-wallace-md/3527f127-26e3-41e1-9e59-f8fa618a9260
Source feed: FDA_Inspections

> FDA inspection 1055969 of Paul W. Wallace, MD, June 08, 2018. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 312. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1055969
- Company Name: Paul W. Wallace, MD
- Inspection Date: 2018-06-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1307736 - 2026-03-17](https://www.keypedia.com/records/fda_inspections/paul-w-wallace-md/f6ed70f6-0bc5-4521-9c11-8fcd6786192e)
- FDA Inspection 1208694 - 2023-06-16

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/theressa-b-smith/80f0c339-7eac-4c73-b9f6-ecb368738fe6)

Company: https://www.keypedia.com/companies/paul-w-wallace-md/c6e736a3-93ff-4b83-aa9d-86fb904877ca

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
